Haisco Pharmaceutical Group Company Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 5,597

Employees

  • Stock Symbol
  • 002653

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $8.70
  • (As of Friday Closing)

Haisco Pharmaceutical Group Company General Information

Description

Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.

Contact Information

Website
www.haisco.com
Formerly Known As
Xizang Haisco Pharmaceutical Group Company, Chengdu Borui Pharmaceutical Technology Development
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 43 Wenxiong Avenue
  • Nedong District
  • Shannan, Tibet 856000
  • China
+86 028
Primary Industry
Medical Supplies
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Number 43 Wenxiong Avenue
  • Nedong District
  • Shannan, Tibet 856000
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Haisco Pharmaceutical Group Company Stock Performance

As of 13-Nov-2026, Haisco Pharmaceutical Group Company’s stock price is $8.70. Its current market cap is $9.9B with 1.14B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.70 $8.82 $6.14 - $11.90 $9.9B 1.14B 4.83M $0.17

Haisco Pharmaceutical Group Company Financials Summary

As of 30-Sep-2026, Haisco Pharmaceutical Group Company has a trailing 12-month revenue of $879M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 10,624,396 8,345,089 5,207,125 3,728,061
Revenue 878,914 610,150 518,622 474,223
EBITDA 188,777 77,661 101,264 77,042
Net Income 189,125 36,096 55,112 41,713
Total Assets 1,344,738 1,001,973 931,280 938,533
Total Debt 338,421 282,931 261,694 254,846
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Haisco Pharmaceutical Group Company Patents

Haisco Pharmaceutical Group Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026228726-A1 C-kit inhibitor and use thereof Pending 29-Apr-2025
WO-2026228427-A1 Pharmaceutical composition of complement factor b inhibitor and use thereof Pending 29-Apr-2025
WO-2026219300-A1 Large heterocyclic alk inhibitor and pharmaceutical use thereof Pending 17-Apr-2025
WO-2026201022-A1 Substituted heterocyclic compound and use thereof Pending 28-Mar-2025
WO-2026200881-A1 Gip receptor antagonist and pharmaceutical use thereof Pending 24-Mar-2025
To view Haisco Pharmaceutical Group Company’s complete patent history, request access »

Haisco Pharmaceutical Group Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Haisco Pharmaceutical Group Company Investments (10)

Haisco Pharmaceutical Group Company’s most recent deal was a Later Stage VC with Yixin Medical Devices. The deal was made on 21-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Yixin Medical Devices 21-Dec-2023 Later Stage VC Therapeutic Devices
eXIthera Pharmaceuticals 01-Apr-2019 Later Stage VC Drug Discovery
Pneuma Respiratory 02-Dec-2018 Early Stage VC Therapeutic Devices
Laminate Medical Technologies 07-Feb-2017 Later Stage VC Therapeutic Devices
Regentis Biomaterials 05-Feb-2016 Later Stage VC Therapeutic Devices
You’re viewing 5 of 10 investments. Get the full list »

Haisco Pharmaceutical Group Company ESG

Risk Overview

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Haisco Pharmaceutical Group Company’s complete esg history, request access »

Haisco Pharmaceutical Group Company Exits (5)

Haisco Pharmaceutical Group Company’s most recent exit was on 01-Apr-2019 from eXIthera Pharmaceuticals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
eXIthera Pharmaceuticals 01-Apr-2019 Completed
Regentis Biomaterials 05-Feb-2016 Completed
  • 8 buyers
Hinova Pharmaceuticals 01-Jan-2016 Completed
Endospan 21-Oct-2015 Completed
  • 4 buyers
Medical Surgery Technologies 30-Jun-2015 Later Stage VC Completed
  • 8 buyers
To view Haisco Pharmaceutical Group Company’s complete exits history, request access »

Haisco Pharmaceutical Group Company FAQs

  • When was Haisco Pharmaceutical Group Company founded?

    Haisco Pharmaceutical Group Company was founded in 2000.

  • Where is Haisco Pharmaceutical Group Company headquartered?

    Haisco Pharmaceutical Group Company is headquartered in Shannan, China.

  • What is the size of Haisco Pharmaceutical Group Company?

    Haisco Pharmaceutical Group Company has 5,597 total employees.

  • What industry is Haisco Pharmaceutical Group Company in?

    Haisco Pharmaceutical Group Company’s primary industry is Medical Supplies.

  • Is Haisco Pharmaceutical Group Company a private or public company?

    Haisco Pharmaceutical Group Company is a Public company.

  • What is Haisco Pharmaceutical Group Company’s stock symbol?

    The ticker symbol for Haisco Pharmaceutical Group Company is 002653.

  • What is the current stock price of Haisco Pharmaceutical Group Company?

    As of 13-Nov-2026 the stock price of Haisco Pharmaceutical Group Company is $8.70.

  • What is the current market cap of Haisco Pharmaceutical Group Company?

    The current market capitalization of Haisco Pharmaceutical Group Company is $9.9B.

  • What is Haisco Pharmaceutical Group Company’s current revenue?

    The trailing twelve month revenue for Haisco Pharmaceutical Group Company is $879M.

  • What is Haisco Pharmaceutical Group Company’s annual earnings per share (EPS)?

    Haisco Pharmaceutical Group Company’s EPS for 12 months was $0.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process